Statin therapy is a cornerstone of secondary prevention in adults with atherosclerotic cardiovascular disease; it reduces the risk of subsequent myocardial infarction, stroke, revascularization, and cardiovascular death. Because of their greater efficacy compared with moderate-intensity statins,1 high-intensity statins received a class I recommendation for adults 75 years and younger with atherosclerotic cardiovascular disease in the 2013 American College of Cardiology/American Heart Association cholesterol guidelines.
Navar AM, Fonarow GC. Regional Differences in Secondary Prevention Therapy—Geography Should Not Be Destiny. JAMA Cardiol. Published online July 24, 2019. doi:10.1001/jamacardio.2019.2548
Browse and subscribe to JAMA Network podcasts!
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: